| __timestamp | Pfizer Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 14097000000 | 305409000 |
| Thursday, January 1, 2015 | 14809000000 | 377080000 |
| Friday, January 1, 2016 | 14837000000 | 432829000 |
| Sunday, January 1, 2017 | 14784000000 | 496079000 |
| Monday, January 1, 2018 | 14455000000 | 557616000 |
| Tuesday, January 1, 2019 | 14350000000 | 658498000 |
| Wednesday, January 1, 2020 | 11615000000 | 770456000 |
| Friday, January 1, 2021 | 12703000000 | 840100000 |
| Saturday, January 1, 2022 | 13677000000 | 944700000 |
| Sunday, January 1, 2023 | 14771000000 | 1136600000 |
| Monday, January 1, 2024 | 14730000000 | 1464300000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of major players is crucial. Over the past decade, Pfizer Inc. and Vertex Pharmaceuticals have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Pfizer's SG&A costs have remained relatively stable, averaging around $14 billion annually, with a slight dip in 2020. In contrast, Vertex Pharmaceuticals has seen a significant rise, with expenses growing nearly fourfold from $305 million in 2014 to over $1.1 billion in 2023. This growth reflects Vertex's aggressive expansion and investment in innovation. While Pfizer's expenses are nearly 20 times higher than Vertex's, the latter's rapid increase highlights its emerging influence in the sector. This comparison offers a fascinating glimpse into the strategic priorities of these pharmaceutical titans.
Novo Nordisk A/S or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Revenue Showdown: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Pfizer Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Pfizer Inc. vs Cytokinetics, Incorporated Trends and Insights
Pfizer Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Blueprint Medicines Corporation
Vertex Pharmaceuticals Incorporated vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Vertex Pharmaceuticals Incorporated vs Evotec SE: SG&A Expense Trends